| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0005 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.83 | 0.0007 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.001 |